Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Towards routine proteome profiling of FFPE tissue: insights from a 1,220-case pan-cancer study.
Tüshaus J, Eckert S, Schliemann M, Zhou Y, Pfeiffer P, Halves C, Fusco F, Weigel J, Hönikl L, Butenschön V, Todorova R, Rauert-Wunderlich H, The M, Rosenwald A, Heinemann V, Holch J, Steiger K, Delbridge C, Meyer B, Weichert W, Mogler C, Kuhn PH, Kuster B. Tüshaus J, et al. Among authors: rauert wunderlich h. EMBO J. 2025 Jan;44(1):304-329. doi: 10.1038/s44318-024-00289-w. Epub 2024 Nov 18. EMBO J. 2025. PMID: 39558110 Free PMC article.
Impact of therapeutic inhibition of oncogenic cell signaling tyrosine kinase on cell metabolism: in vivo-detectable metabolic biomarkers of inhibition.
Nath K, Gupta PK, Basappa J, Wang S, Sen N, Lobello C, Tomar JS, Shestov AA, Orlovskiy S, Arias-Mendoza F, Rauert-Wunderlich H, Nelson DS, Glickson JD, Wasik MA. Nath K, et al. Among authors: rauert wunderlich h. J Transl Med. 2024 Jul 4;22(1):622. doi: 10.1186/s12967-024-05371-9. J Transl Med. 2024. PMID: 38965536 Free PMC article.
Functional Investigation of IGF1R Mutations in Multiple Myeloma.
Heredia-Guerrero SC, Evers M, Keppler S, Schwarzfischer M, Fuhr V, Rauert-Wunderlich H, Krügl A, Nedeva T, Grieb T, Pickert J, Koch H, Steinbrunn T, Bayrhof OJ, Bargou RC, Rosenwald A, Stühmer T, Leich E. Heredia-Guerrero SC, et al. Among authors: rauert wunderlich h. Cancers (Basel). 2024 Jun 4;16(11):2139. doi: 10.3390/cancers16112139. Cancers (Basel). 2024. PMID: 38893258 Free PMC article.
EGR1 changes course in B-cell lymphoma.
Rauert-Wunderlich H. Rauert-Wunderlich H. Blood. 2023 Nov 30;142(22):1850-1851. doi: 10.1182/blood.2023022493. Blood. 2023. PMID: 38032671 Free article. No abstract available.
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell-redirecting therapy.
Duell J, Leipold AM, Appenzeller S, Fuhr V, Rauert-Wunderlich H, Da Via M, Dietrich O, Toussaint C, Imdahl F, Eisele F, Afrin N, Grundheber L, Einsele H, Weinhold N, Rosenwald A, Topp MS, Saliba AE, Rasche L. Duell J, et al. Among authors: rauert wunderlich h. Blood. 2024 Feb 22;143(8):685-696. doi: 10.1182/blood.2023021672. Blood. 2024. PMID: 37976456
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma.
Fuhr V, Heidenreich S, Srivastava M, Riedel A, Düll J, Gerhard-Hartmann E, Rosenwald A, Rauert-Wunderlich H. Fuhr V, et al. Among authors: rauert wunderlich h. Cell Death Discov. 2022 Dec 31;8(1):505. doi: 10.1038/s41420-022-01289-7. Cell Death Discov. 2022. PMID: 36587029 Free PMC article.
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT.
Duell J, Krummenast F, Schirbel A, Klassen P, Samnick S, Rauert-Wunderlich H, Rasche L, Buck AK, Wester HJ, Rosenwald A, Einsele H, Topp MS, Lapa C, Kircher M. Duell J, et al. Among authors: rauert wunderlich h. J Nucl Med. 2021 Oct;62(10):1415-1421. doi: 10.2967/jnumed.120.257279. Epub 2021 Feb 12. J Nucl Med. 2021. PMID: 33579803 Free article.
21 results